O	O	0	3	HIV	HIV	B-NP	NN	O	4	NMOD	O
O	O	3	4	-	-	B-NP	HYPH	O	1	P	O
O	O	4	5	1	1	I-NP	CD	O	4	NMOD	O
T1	B-Protein	6	9	Nef	Nef	I-NP	NN	B-protein	5	SUB	B-protein
O	O	10	15	leads	lead	B-VP	VBZ	O	0	ROOT	O
O	O	16	18	to	to	B-PP	TO	O	5	VMOD	O
O	O	19	29	inhibition	inhibition	B-NP	NN	O	9	NMOD	O
O	O	30	32	or	or	I-NP	CC	O	9	NMOD	O
O	O	33	43	activation	activation	I-NP	NN	O	6	PMOD	O
O	O	44	46	of	of	B-PP	IN	O	9	NMOD	O
O	O	47	48	T	T	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	49	54	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	55	64	depending	depend	B-PP	VBG	O	5	VMOD	O
O	O	65	67	on	on	B-PP	IN	O	13	PMOD	O
O	O	68	71	its	its	B-NP	PRP$	O	17	NMOD	O
O	O	72	85	intracellular	intracellular	I-NP	JJ	O	17	NMOD	O
O	O	86	98	localization	localization	I-NP	NN	O	14	PMOD	O
O	O	98	99	.	.	O	.	O	5	P	O

T2	B-Protein	101	104	Nef	Nef	B-NP	NN	B-protein	5	SUB	B-protein
O	O	105	107	of	of	B-PP	IN	O	1	NMOD	O
O	O	108	115	primate	primate	B-NP	JJ	O	4	NMOD	O
O	O	116	128	lentiviruses	lentivirus	I-NP	NNS	O	2	PMOD	O
O	O	129	131	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	132	140	required	require	I-VP	VBN	O	5	VC	O
O	O	141	144	for	for	B-PP	IN	O	6	VMOD	O
O	O	145	152	viremia	viremia	B-NP	NN	O	10	NMOD	O
O	O	153	156	and	and	I-NP	CC	O	10	NMOD	O
O	O	157	168	progression	progression	I-NP	NN	O	7	PMOD	O
O	O	169	171	to	to	B-PP	TO	O	10	NMOD	O
O	O	172	176	AIDS	AIDS	B-NP	NN	O	11	PMOD	O
O	O	177	179	in	in	B-PP	IN	O	10	NMOD	O
O	O	180	187	monkeys	monkey	B-NP	NNS	O	13	PMOD	O
O	O	187	188	.	.	O	.	O	5	P	O

O	O	189	197	Negative	Negative	B-ADVP	JJ	O	7	NMOD	O
O	O	197	198	,	,	O	,	O	7	P	O
O	O	199	207	positive	positive	B-ADJP	JJ	O	7	NMOD	O
O	O	207	208	,	,	O	,	O	7	P	O
O	O	209	212	and	and	O	CC	O	7	NMOD	O
O	O	213	215	no	no	B-NP	DT	O	7	NMOD	O
O	O	216	223	effects	effect	I-NP	NNS	O	10	SUB	O
O	O	224	226	of	of	B-PP	IN	O	7	NMOD	O
T3	B-Protein	227	230	Nef	Nef	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	231	235	have	have	B-VP	VBP	O	0	ROOT	O
O	O	236	240	also	also	I-VP	RB	O	10	VMOD	O
O	O	241	245	been	be	I-VP	VBN	O	10	VC	O
O	O	246	254	reported	report	I-VP	VBN	O	12	VC	O
O	O	255	257	on	on	B-PP	IN	O	13	VMOD	O
O	O	258	263	viral	viral	B-NP	JJ	O	16	NMOD	O
O	O	264	275	replication	replication	I-NP	NN	O	14	PMOD	O
O	O	276	278	in	in	B-PP	IN	O	16	NMOD	O
O	O	279	284	cells	cell	B-NP	NNS	O	17	PMOD	O
O	O	284	285	.	.	O	.	O	10	P	O

O	O	286	288	To	To	B-VP	TO	O	2	VMOD	O
O	O	289	298	reconcile	reconcile	I-VP	VB	O	7	VMOD	O
O	O	299	304	these	these	B-NP	DT	O	4	NMOD	O
O	O	305	317	observations	observation	I-NP	NNS	O	2	OBJ	O
O	O	317	318	,	,	O	,	O	7	P	O
O	O	319	321	we	we	B-NP	PRP	O	7	SUB	O
O	O	322	331	expressed	express	B-VP	VBD	O	0	ROOT	O
O	O	332	333	a	a	B-NP	DT	O	13	NMOD	O
O	O	334	340	hybrid	hybrid	I-NP	NN	B-protein	13	NMOD	B-protein
T12	B-Entity	341	344	CD8	CD8	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	344	345	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T4	B-Protein	345	348	Nef	Nef	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	349	356	protein	protein	I-NP	NN	I-protein	7	OBJ	I-protein
O	O	357	359	in	in	B-PP	IN	O	7	VMOD	O
O	O	360	366	Jurkat	Jurkat	B-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	367	372	cells	cell	I-NP	NNS	I-cell_line	14	PMOD	I-cell_line
O	O	372	373	.	.	O	.	O	7	P	O

O	O	374	377	Two	Two	B-NP	CD	O	3	NMOD	O
O	O	378	386	opposite	opposite	I-NP	JJ	O	3	NMOD	O
O	O	387	397	phenotypes	phenotype	I-NP	NNS	O	4	SUB	O
O	O	398	402	were	be	B-VP	VBD	O	0	ROOT	O
O	O	403	408	found	find	I-VP	VBN	O	4	VC	O
O	O	408	409	,	,	O	,	O	4	P	O
O	O	410	415	which	which	B-NP	WDT	O	4	VMOD	O
O	O	416	424	depended	depend	B-VP	VBD	O	7	SBAR	O
O	O	425	427	on	on	B-PP	IN	O	8	VMOD	O
O	O	428	431	the	the	B-NP	DT	O	12	NMOD	O
O	O	432	445	intracellular	intracellular	I-NP	JJ	O	12	NMOD	O
O	O	446	458	localization	localization	I-NP	NN	O	9	PMOD	O
O	O	459	461	of	of	B-PP	IN	O	12	NMOD	O
T5	B-Protein	462	465	Nef	Nef	B-NP	NN	B-protein	13	PMOD	B-protein
O	O	465	466	.	.	O	.	O	4	P	O

O	O	467	476	Expressed	Express	B-VP	VBN	O	13	VMOD	O
O	O	477	479	in	in	B-PP	IN	O	1	VMOD	O
O	O	480	483	the	the	B-NP	DT	O	4	NMOD	O
O	O	484	493	cytoplasm	cytoplasm	I-NP	NN	O	2	PMOD	O
O	O	494	496	or	or	B-PP	CC	O	2	PMOD	O
O	O	497	499	on	on	B-PP	IN	O	2	PMOD	O
O	O	500	503	the	the	B-NP	DT	O	9	NMOD	O
O	O	504	508	cell	cell	I-NP	NN	O	9	NMOD	O
O	O	509	516	surface	surface	I-NP	NN	O	6	PMOD	O
O	O	516	517	,	,	O	,	O	13	P	O
O	O	518	521	the	the	B-NP	DT	O	12	NMOD	O
O	O	522	529	chimera	chimera	I-NP	NN	B-protein	13	SUB	B-protein
O	O	530	539	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
O	O	540	542	or	or	I-VP	CC	O	13	VMOD	O
O	O	543	552	activated	activate	I-VP	VBD	O	13	VMOD	O
O	O	553	558	early	early	B-NP	JJ	O	18	NMOD	O
O	O	559	568	signaling	signaling	I-NP	NN	O	18	NMOD	O
O	O	569	575	events	event	I-NP	NNS	O	13	VMOD	O
O	O	576	580	from	from	B-PP	IN	O	18	NMOD	O
O	O	581	584	the	the	B-NP	DT	O	24	NMOD	O
T13	B-Entity	585	586	T	T	I-NP	NN	B-protein	24	NMOD	B-protein
T13	I-Entity	587	591	cell	cell	I-NP	NN	I-protein	24	NMOD	I-protein
T13	I-Entity	592	599	antigen	antigen	I-NP	NN	I-protein	24	NMOD	I-protein
T13	I-Entity	600	608	receptor	receptor	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	608	609	.	.	O	.	O	13	P	O

O	O	610	619	Activated	Activate	B-NP	VBN	O	3	NMOD	O
O	O	620	626	Jurkat	Jurkat	I-NP	NN	B-cell_line	3	NMOD	B-cell_line
O	O	627	632	cells	cell	I-NP	NNS	I-cell_line	4	SUB	I-cell_line
O	O	633	637	died	die	B-VP	VBD	O	18	VMOD	O
O	O	638	640	by	by	B-PP	IN	O	4	VMOD	O
O	O	641	650	apoptosis	apoptosis	B-NP	NN	O	5	PMOD	O
O	O	650	651	,	,	O	,	O	18	P	O
O	O	652	655	and	and	O	CC	O	18	VMOD	O
O	O	656	660	only	only	B-NP	RB	O	10	NMOD	O
O	O	661	666	cells	cell	I-NP	NNS	O	18	SUB	O
O	O	667	671	with	with	B-PP	IN	O	10	NMOD	O
O	O	672	679	mutated	mutate	B-NP	VBN	B-DNA	14	NMOD	B-DNA
T6	B-Protein	680	683	nef	nef	I-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	684	689	genes	gene	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	690	700	expressing	express	B-VP	VBG	O	14	NMOD	O
O	O	701	710	truncated	truncate	B-NP	VBN	O	17	NMOD	O
T7	B-Protein	711	715	Nefs	Nef	I-NP	NNS	B-protein	15	OBJ	B-protein
O	O	716	724	survived	survive	B-VP	VBD	O	0	ROOT	O
O	O	724	725	,	,	O	,	O	18	P	O
O	O	726	731	which	which	B-NP	WDT	O	18	VMOD	O
O	O	732	740	rendered	render	B-VP	VBD	O	20	SBAR	O
T8	B-Protein	741	744	Nef	Nef	B-NP	NN	B-protein	21	VMOD	B-protein
O	O	745	758	nonfunctional	nonfunctional	B-ADJP	JJ	O	22	PRD	O
O	O	758	759	.	.	O	.	O	18	P	O

O	O	760	765	These	These	B-NP	DT	O	2	NMOD	O
O	O	766	775	mutations	mutation	I-NP	NNS	O	3	SUB	O
O	O	776	786	paralleled	parallel	B-VP	VBD	O	0	ROOT	O
O	O	787	792	those	those	B-NP	DT	O	3	OBJ	O
O	O	793	795	in	in	B-PP	IN	O	4	NMOD	O
O	O	796	801	other	other	B-NP	JJ	O	8	NMOD	O
O	O	802	807	viral	viral	I-NP	JJ	O	8	NMOD	O
O	O	808	815	strains	strain	I-NP	NNS	O	5	PMOD	O
O	O	816	824	passaged	passage	B-VP	VBN	O	8	NMOD	O
O	O	825	827	in	in	B-ADVP	FW	O	9	VMOD	O
O	O	828	833	vitro	vitro	I-ADVP	FW	O	10	AMOD	O
O	O	833	834	.	.	O	.	O	3	P	O

O	O	835	838	Not	Not	O	RB	O	3	VMOD	O
O	O	839	843	only	only	B-VP	RB	O	1	DEP	O
O	O	844	846	do	do	I-VP	VB	O	28	VMOD	O
O	O	847	852	these	these	B-NP	DT	O	6	NMOD	O
O	O	853	863	positional	positional	I-NP	JJ	O	6	NMOD	O
O	O	864	871	effects	effect	I-NP	NNS	O	3	SUB	O
O	O	872	874	of	of	B-PP	IN	O	6	NMOD	O
T9	B-Protein	875	878	Nef	Nef	B-NP	NN	B-protein	7	PMOD	B-protein
O	O	879	888	reconcile	reconcile	B-VP	VBP	O	3	VMOD	O
O	O	889	896	diverse	diverse	B-NP	JJ	O	11	NMOD	O
O	O	897	907	phenotypes	phenotype	I-NP	NNS	O	9	OBJ	O
O	O	908	910	of	of	B-PP	IN	O	11	NMOD	O
T10	B-Protein	911	914	Nef	Nef	B-NP	NN	B-protein	12	PMOD	B-protein
O	O	915	918	and	and	O	CC	O	9	VMOD	O
O	O	919	926	suggest	suggest	B-VP	VBP	O	9	VMOD	O
O	O	927	928	a	a	B-NP	DT	O	17	NMOD	O
O	O	929	933	role	role	I-NP	NN	O	15	OBJ	O
O	O	934	937	for	for	B-PP	IN	O	17	NMOD	O
O	O	938	941	its	its	B-NP	PRP$	O	23	NMOD	O
O	O	942	943	N	N	I-NP	NN	O	23	NMOD	O
O	O	943	944	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	944	952	terminal	terminal	I-NP	JJ	O	23	NMOD	O
O	O	953	966	myristylation	myristylation	I-NP	NN	O	18	PMOD	O
O	O	966	967	,	,	O	,	O	28	P	O
O	O	968	971	but	but	O	CC	O	28	VMOD	O
O	O	972	976	they	they	B-NP	PRP	O	28	SUB	O
O	O	977	981	also	also	B-ADVP	RB	O	28	VMOD	O
O	O	982	989	explain	explain	B-VP	VBP	O	0	ROOT	O
O	O	990	997	effects	effect	B-NP	NNS	O	28	OBJ	O
O	O	998	1000	of	of	B-PP	IN	O	29	NMOD	O
T11	B-Protein	1001	1004	Nef	Nef	B-NP	NN	B-protein	30	PMOD	B-protein
O	O	1005	1007	in	in	B-PP	IN	O	29	NMOD	O
O	O	1008	1011	HIV	HIV	B-NP	NN	O	34	NMOD	O
O	O	1012	1021	infection	infection	I-NP	NN	O	36	NMOD	O
O	O	1022	1025	and	and	I-NP	CC	O	36	NMOD	O
O	O	1026	1037	progression	progression	I-NP	NN	O	32	PMOD	O
O	O	1038	1040	to	to	B-PP	TO	O	36	NMOD	O
O	O	1041	1045	AIDS	AIDS	B-NP	NNP	O	37	PMOD	O
O	O	1045	1046	.	.	O	.	O	28	P	O
